Products - Renal cancer | Topic | NICE

Showing 4 products

Date | Title

Status: In developmentRemove ‘Status: In development’ filter

Renal cell carcinoma Pathways Pilot [ID6186]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Suspected cancer update
Status:
In development
Expected publication date:
TBC
Savolitinib with durvalumab for treating MET-driven unresectable advanced papillary renal cell carcinoma [ID6520]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Belzutifan with pembrolizumab and lenvatinib for untreated advanced clear cell renal cell carcinoma [ID6605]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC